TFIIB-related factor 2 inhibits lung squamous carcinoma cell apoptosis through SLC8A3-mediated mitochondrial

Shen Yi1, Xing Qi2, Fei Luo1

  • 1Department of Thoracic Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

PubMed

Insights

TFIIB-related factor 2 (BRF2) upregulation in lung squamous cell carcinoma (LUSC) promotes tumor growth by increasing SLC8A3, stabilizing mitochondrial function, and reducing apoptosis. This reveals BRF2 as a potential therapeutic target for LUSC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Lung cancer is a leading cause of cancer deaths, necessitating novel therapeutic targets.
  • TFIIB-related factor 2 (BRF2) is implicated in tumor development, but its role in lung squamous carcinoma (LUSC) remains undefined.

Purpose of the Study:

  • To investigate the regulatory mechanism and functional role of BRF2 in LUSC development.
  • To elucidate the downstream targets and signaling pathways affected by BRF2 in LUSC.

Main Methods:

  • Flow cytometry, Western blotting, and in vivo experiments assessed BRF2 function.
  • Transmission electron microscopy and mitochondrial membrane potential (MMP) assays evaluated mitochondrial effects.
  • Bioinformatics, qRT-PCR, and immunoprecipitation (IP) assays identified and confirmed SLC8A3 as a downstream mediator.

Main Results:

  • BRF2 was upregulated in LUSC, increasing SLC8A3 expression and promoting mitochondrial autophagy.
  • BRF2 stabilized MMP and reduced apoptosis in LUSC cells.
  • SLC8A3 overexpression counteracted BRF2 knockdown effects by inhibiting PINK1-TIMM23 interaction, further promoting mitochondrial autophagy.

Conclusions:

  • BRF2 maintains mitochondrial homeostasis in LUSC by mediating SLC8A3 expression, thereby reducing apoptosis.
  • BRF2 and its downstream effector SLC8A3 represent promising therapeutic targets for LUSC treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K